Clinical Scorecard: Comparative Analysis of Long-term Quality of Life and Chronic Pain Following Surgical and Non-surgical Approaches for Rib Fractures: A Systematic Review and Meta-Analysis

At a Glance

Key Highlights

• No significant difference in long-term HRQoL (≥3 months) between SSRF and non-operative groups.
• Higher risk of chronic chest wall pain ≥3 months after SSRF compared to non-operative management (RR 1.28).
• Tracheostomy rates did not differ significantly between SSRF and non-operative treatment groups.

Guideline-Based Recommendations

Diagnosis

• Assess rib fractures in adults with traumatic injury using clinical and imaging evaluation.
• Evaluate patient-reported outcomes including HRQoL and chronic chest wall pain at ≥3 months post-injury.

Management

• Consider SSRF primarily for short-term physiological benefits in selected patients with flail chest or severe displacement.
• Non-operative management remains standard for most rib fractures given lack of demonstrated long-term HRQoL benefit from SSRF.
• Inform patients about potential increased risk of chronic chest wall pain following SSRF.

Monitoring & Follow-up

• Perform standardized long-term follow-up assessments of HRQoL and chronic pain at intervals ≥3 months post-injury.
• Monitor for chronic chest wall pain and neuropathic symptoms regardless of treatment modality.

Risks

• SSRF may be associated with increased chronic chest wall pain potentially due to nerve injury, surgical scarring, or implant discomfort.
• No significant difference in tracheostomy risk between SSRF and non-operative management.

Patient & Prescribing Data

Adults with traumatic rib fractures undergoing SSRF or non-operative treatment

SSRF does not improve long-term HRQoL and may increase chronic chest wall pain risk; non-operative management remains appropriate for many patients.

Clinical Best Practices

• Use shared decision-making to discuss benefits and risks of SSRF versus non-operative care focusing on long-term outcomes.
• Prioritize non-operative management for rib fractures unless specific indications for SSRF exist.
• Implement standardized protocols for long-term assessment of HRQoL and chronic pain.
• Recognize multifactorial causes of chronic pain post-rib fracture and tailor pain management accordingly.
• Encourage prospective studies with standardized outcome measures to better define long-term effects of SSRF.

References

• PROSPERO Registration CRD420251245598
• PRISMA 2020 Guidelines
• Cochrane Handbook for Systematic Reviews of Interventions